Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you use bolus in patients s/p mastectomy and reconstruction if they had dermal involvement?
Answer from: Radiation Oncologist at Community Practice
Pathological dermis involvement is a risk factor of LR and I would use bolus for this situation.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
While we are increasingly omitting bolus, dermal involvement would concern me and I would use bolus.
Comments
Radiation Oncologist at University of Miami/Jackson Memorial Medical Center
Drs. @Sushil Beriwal and @Chirag S. Shah, would yo...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
I typically start with 1st 13 fractions and will m...
Radiation Oncologist at Indiana University Health
@Sushil Beriwal @Chirag S. Shah Would you consider...
9600
9602
15122
Sign in or Register to read more
11755
11772
Related Questions
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
What is the appropriate approach to manage a patient with triple-negative, locally advanced breast cancer (LN+) who progresses on neoadjuvant chemo-immunotherapy (KEYNOTE-522 regimen)?
Does your dosimetrist use skin flash for VMAT whole breast or RNI plans?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
Is DCISionRT appropriate for multifocal DCIS?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
Should PMRT be offered for ypN0(i+) disease if only 1-2 nodes were removed in the post-chemotherapy SLNB and there is no plan for a completion AxLND?